(Photo credit: mySugr) Roche's diabetes management app mySugr's Logbook is now integrating with Novo Nordisk's connected insulin pens: the NovoPen 6 and NovoPen Echo Plus. Patients will be able connect the mySugr Logbook to their smart-pen device in order to create more data set and reports with more insights. According to the companies, the goal is to be able to share more insights with healthcare providers in order to guide disease management. This new effort comes after the Swiss pharma giant signed a collaboration deal with the diabetes company in 2019. WHY IT MATTERS Diabetes is a common condition around the world. According to the World Health Organization, about 422 million people are living with diabetes, and the condition is directly attributed to 1.6 million deaths a year.